TCM

Tybourne Capital Management Portfolio holdings

AUM $30.9M
1-Year Est. Return 20.1%
This Quarter Est. Return
1 Year Est. Return
+20.1%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$30.9M
AUM Growth
-$3.61M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$6.91M
2
+$2.09M
3
+$1.29M
4
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$780K

Sector Composition

1 Healthcare 100%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
1
Taysha Gene Therapies
TSHA
$1.42B
$12.1M 39.11%
3,700,000
-395,000
FBRX icon
2
Forte Biosciences
FBRX
$257M
$11.8M 38.15%
786,647
ALMS
3
Alumis Inc
ALMS
$1.04B
$5.58M 18.05%
1,399,250
ZNTL icon
4
Zentalis Pharmaceuticals
ZNTL
$102M
$1.45M 4.69%
961,486
-516,666
BCYC
5
Bicycle Therapeutics
BCYC
$499M
– –
-993,743
MBUU icon
6
Malibu Boats
MBUU
$543M
– –
-66,705